Trademark Attorney / Law Firm
Daniel S. Elimelech – Trademark Portfolio
Daniel S. Elimelech specializes in Class 35 (Advertising & Business) trademark filings before the United States Patent and Trademark Office (USPTO), with 1 of 2 total filings concentrated in this category. The practice also covers Class 42 (Computer & Scientific) along with 3 other Nice Classification classes. Filing activity spans from 2018 to 2019. Currently, 1 trademark is registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Daniel S. Elimelech's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademark applications has Daniel S. Elimelech filed?
Daniel S. Elimelech has filed 2 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 1 abandoned.
What trademark classes does Daniel S. Elimelech specialize in?
Daniel S. Elimelech has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). Class 35 covers advertising; business management; business administration; office functions.
How long has Daniel S. Elimelech been filing trademarks?
Daniel S. Elimelech's trademark filing history with the USPTO spans from 2018 to 2019, covering 1 year of trademark practice. During this period, Daniel S. Elimelech has handled 2 trademark applications.
What is Daniel S. Elimelech's trademark registration success rate?
Daniel S. Elimelech has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.